Funded Tech Companies
Epizyme
Epizyme is a biopharmaceutical company, based in Cambridge. Venture investment and financing came from New Enterprise Associates, MPM Capital and private investors.
Company Overview
Company Name
Epizyme
Company Status
Publicly-held
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
400 Technology Sq. 4th Floor
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Website
Email Address
Company Background Information
Overview
Epizyme, Inc., a clinical stage biopharmaceutical company, discovers and develops epigenetic therapies for cancer patients. The company?s proprietary product platform creates small molecule inhibitors of enzymes known as histone methyltransferases (HMTs).
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
5/31/2013
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Robert Bazemore
Chief Financial Officer
Paolo Tombesi
Chief Medical Officer
Shefali Agarwal
Chief Operating Officer
Matthew Ros
VP - General Counsel
John Weidenbruch
VP - Regulatory Affairs
Mark De Rosch
Company Investors
- New Enterprise Associates (David Mott)
- MPM Capital (Kazumi Shiosaki)
- Amgen Ventures
- Bay City Capital (Carl Goldfischer)
- Kleiner Perkins Caufield & Byers (Beth Seidenberg)
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs